Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

BRD4: New hope in the battle against glioblastoma
Weichen Duan, Miao Yu, Jiajia Chen
Pharmacological Research (2023) Vol. 191, pp. 106767-106767
Open Access | Times Cited: 16

Showing 16 citing articles:

Target protein degradation by protacs: A budding cancer treatment strategy
Diksha Choudhary, Amritpal Kaur, Pargat Singh, et al.
Pharmacology & Therapeutics (2023) Vol. 250, pp. 108525-108525
Closed Access | Times Cited: 8
Molecular subgroup establishment and signature creation of lncRNAs associated with acetylation in lung adenocarcinoma
Hao Chen, Yuanyong Wang, Changjian Shao, et al.
Aging (2024) Vol. 16, Iss. 2, pp. 1276-1297
Open Access | Times Cited: 2
Mechanistic insights into super-enhancer-driven genes as prognostic signatures in patients with glioblastoma
Youran Chen, Yi Pan, Hanyu Gao, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 13, pp. 12315-12332
Closed Access | Times Cited: 6
Effects of BRD4 inhibitor JQ1 on the expression profile of super-enhancer related lncRNAs and mRNAs in cervical cancer HeLa cells
Jianqing Zheng, Bifen Huang, Li-hua Xiao, et al.
PeerJ (2024) Vol. 12, pp. e17035-e17035
Open Access | Times Cited: 1
Epigenetic clocks and gliomas: unveiling the molecular interactions between aging and tumor development
Shiliang Chen, Yi Jiang, Cong Wang, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 1
Enhancing therapeutic efficacy in homologous recombination-proficient pancreatic cancer via the combination of PARP1-PROTAC and a BRD4 inhibitor
Chunlan Pu, Yuanyuan Liu, Suke Lan, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 115, pp. 117970-117970
Closed Access | Times Cited: 1
Non-coding RNAs: Emerging biomarkers and therapeutic targets in ulcerative colitis
Imran Kazmi, Abdulmalik Saleh Alfawaz Altamimi, Muhammad Afzal, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 155037-155037
Closed Access | Times Cited: 3
Review on: BRD4 inhibitors for anticancer research
Vindhya Vikram Singh, Shafqat Alauddin
Human Gene (2023) Vol. 37, pp. 201196-201196
Closed Access | Times Cited: 2
BRD4-specific PROTAC inhibits basal-like breast cancer partially through downregulating KLF5 expression
Ceshi Chen, Yanjie Kong, Tianlong Lan, et al.
Research Square (Research Square) (2024)
Open Access
Targeting Epigenetic Readers Using Small Molecule Binders and PROTAC Degraders
Eleonora Boccia, Erica Gazzillo, Maria Giovanna Chini, et al.
Interdisciplinary cancer research (2024)
Closed Access
A Review of the Bromodomain and Extraterminal Domain Epigenetic Reader Proteins: Function on Virus Infection and Cancer
Mengli Wu, Guiquan Guan, Hong Yin, et al.
Viruses (2024) Vol. 16, Iss. 7, pp. 1096-1096
Open Access
BRD4-specific PROTAC inhibits basal-like breast cancer partially through downregulating KLF5 expression
Yanjie Kong, Tianlong Lan, Luzhen Wang, et al.
Oncogene (2024) Vol. 43, Iss. 39, pp. 2914-2926
Open Access
Bromodomain containing 4 inhibition combats gastric precancerous lesions via modulating macrophage polarization
Lei Zhu, Qingxin Cai, Gang Li, et al.
Tissue and Cell (2024) Vol. 91, pp. 102580-102580
Closed Access
BET inhibitor and CDK4/6 inhibitor synergistically inhibit breast cancer by suppressing BRD4 stability and DNA damage repair
Shuaishuai Chi, Wei Fan, Yangsha Li, et al.
Translational Oncology (2024) Vol. 51, pp. 102212-102212
Closed Access
BF3⋅Et2O‐Catalyzed Selective C‐4 Alkylation of Isoquinolin‐1(2H)‐ones Employing p‐Quinone Methides
Devidas A. More, Ganesh S. Ghotekar, M. Muthukrishnan
Chemistry - An Asian Journal (2023) Vol. 18, Iss. 17
Closed Access | Times Cited: 1
Molecular Subgroup Establishment and Signature Creation of lncRNAs Associated with Acetylation in Lung Adenocarcinoma
Hao Chen, Yuanyong Wang, Changjian Shao, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top